From taste hedonics to motivational drive: central μ-opioid receptors and binge-eating behaviour.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  International Journal of Neuropsychopharmacology

• Publication date

  2009-08-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1017/S146114570900039XPMID 19433009
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dopamine for “Wanting” and Opioids for “Liking”: A Comparison of Obese Adults With and Without Binge Eating

  2009cited by this paper
• Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV)

  2009cited by this paper
• Review and Meta‐analysis of Pharmacotherapy for Binge‐eating Disorder

  2008cited by this paper
• Activation of mesolimbic dopamine neurons during novel and daily limited access to palatable food is blocked by the opioid antagonist LY255582.

  2008cited by this paper
• Opioid-Dependent Anticipatory Negative Contrast and Binge-Like Eating in Rats with Limited Access to Highly Preferred Food

  2008cited by this paper
• Food deprivation increases the mRNA expression of micro-opioid receptors in the ventral medial hypothalamus and arcuate nucleus.

  2008cited by this paper
• High‐dose escitalopram in the treatment of binge‐eating disorder with obesity: a placebo‐controlled monotherapy trial

  2008cited by this paper
• Efficacy of sibutramine for the treatment of binge eating disorder: a randomized multicenter placebo-controlled double-blind study.

  2008cited by this paper
• Stress responsivity, addiction, and a functional variant of the human mu-opioid receptor gene.

  2007cited by this paper
• Decreased motivation to eat in µ‐opioid receptor‐deficient mice

  2007cited by this paper
• Prevalence and correlates of binge eating disorder in a community sample.

  2007cited by this paper
• Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study.

  2007cited by this paper
• A118g polymorphism in mu opioid receptor gene (oprm1): association with opiate addiction in subjects of Indian origin.

  2007cited by this paper
• Topiramate for the treatment of binge eating disorder associated with obesity: a placebo-controlled study.

  2007cited by this paper
• Conditioned place preferences (CPPs) to high-caloric "snack foods" in rat strains genetically prone vs. resistant to diet-induced obesity: resistance to naltrexone blockade.

  2007cited by this paper
• Dietary fat stimulates endogenous enkephalin and dynorphin in the paraventricular nucleus: role of circulating triglycerides.

  2007cited by this paper
• Examining the addictive-like properties of binge eating using an animal model of sugar dependence.

  2007influential reference
• Stress responsivity, addiction, and a functional variant of the human mu-opioid receptor gene.

  2007cited by this paper
• The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication.

  2007cited by this paper
• Atomoxetine in the treatment of binge-eating disorder: a randomized placebo-controlled trial.

  2007cited by this paper
• Discrete neurochemical coding of distinguishable motivational processes: insights from nucleus accumbens control of feeding

  2007cited by this paper
• Central opioids and consumption of sweet tastants: when reward outweighs homeostasis.

  2007cited by this paper
• The mu-opioid receptor subtype is required for the anorectic effect of an opioid receptor antagonist.

  2006cited by this paper
• Differential involvement of endogenous opioids in sucrose consumption and food reinforcement.

  2006cited by this paper
• Differential Regulation of the Consummatory, Motivational and Anticipatory Aspects of Feeding Behavior by Dopaminergic and Opioidergic Drugs

  2006cited by this paper
• Increased expression of mu opioid receptors in animals susceptible to diet-induced obesity.

  2006cited by this paper
• Mu‐opioid receptor cellular function in the nucleus accumbens is essential for hedonically driven eating

  2006cited by this paper
• Targeting opioid receptor heterodimers: Strategies for screening and drug development

  2006cited by this paper
• Zonisamide in the treatment of binge eating disorder with obesity: a randomized controlled trial.

  2006cited by this paper
• Bingeing rats: a model of intermittent excessive behavior?

  2006cited by this paper
• Imaging brain mu-opioid receptors in abstinent cocaine users: time course and relation to cocaine craving.

  2005cited by this paper
• Decreased firing frequency of midbrain dopamine neurons in mice lacking mu opioid receptors

  2005cited by this paper
• Reciprocal opioid-opioid interactions between the ventral tegmental area and nucleus accumbens regions in mediating mu agonist-induced feeding in rats.

  2005cited by this paper
• Everyday dietary behaviour and the relationship between attention and meal size.

  2005cited by this paper
• Efficacy of cognitive behavioral therapy and fluoxetine for the treatment of binge eating disorder: a randomized double-blind placebo-controlled comparison.

  2005cited by this paper
• Use of sibutramine an inhibitor of the reuptake of serotonin and noradrenaline, in the treatment of binge eating disorder: A placebo-controlled study

  2005cited by this paper
• Correlation of stable elevations in striatal mu-opioid receptor availability in detoxified alcoholic patients with alcohol craving: a positron emission tomography study using carbon 11-labeled carfentanil.

  2005cited by this paper
• Daily bingeing on sugar repeatedly releases dopamine in the accumbens shell.

  2005cited by this paper
• Cognitive behavioral therapy and fluoxetine as adjuncts to group behavioral therapy for binge eating disorder.

  2005cited by this paper
• Hedonic Hot Spot in Nucleus Accumbens Shell: Where Do μ-Opioids Cause Increased Hedonic Impact of Sweetness?

  2005cited by this paper
• A proposed hypothalamic–thalamic–striatal axis for the integration of energy balance, arousal, and food reward

  2005cited by this paper
• Regional mu-opioid receptor binding in insular cortex is decreased in bulimia nervosa and correlates inversely with fasting behavior.

  2005cited by this paper
• Epidemiology of Obesity

  2005cited by this paper
• Effect of orlistat in obese patients with binge eating disorder.

  2005cited by this paper
• Increased gabaergic input to ventral tegmental area dopaminergic neurons associated with decreased cocaine reinforcement in mu-opioid receptor knockout mice.

  2005cited by this paper
• Resistance to Diet-Induced Obesity in μ-Opioid Receptor–Deficient Mice: Evidence for a “Thrifty Gene”

  2005cited by this paper
• Increases in food intake or food-seeking behavior induced by GABAergic, opioid, or dopaminergic stimulation of the nucleus accumbens: is it hunger?

  2004cited by this paper
• Substantial attributable risk related to a functional mu-opioid receptor gene polymorphism in association with heroin addiction in central Sweden

  2004cited by this paper
• Modifications of nutrient selection induced by naloxone in rats

  2004cited by this paper
• Central and peripheral contributions of endogenous opioid systems to nutrient selection in rats

  2004cited by this paper
• Effect of exposure to a forbidden food on eating in restrained and unrestrained women.

  2004cited by this paper
• Naltrexone improves blood glucose control in type 1 diabetic women with severe and chronic eating disorders.

  2004cited by this paper
• The amygdala is critical for opioid-mediated binge eating of fat

  2004cited by this paper
• Chronic administration of nalmefene leads to increased food intake and body weight gain in mice.

  2004cited by this paper
• Circulating triglycerides impact on orexigenic peptides and neuronal activity in hypothalamus.

  2004cited by this paper
• Reduction of anxiety after restricted feeding in the rat: implication for eating disorders.

  2004cited by this paper
• A role for heterodimerization of mu and delta opiate receptors in enhancing morphine analgesia.

  2004cited by this paper
• Naloxone: Effects on food and water consumption in the non-deprived and deprived rat

  2004cited by this paper
• A role for heterodimerization of μ and δ opiate receptors in enhancing morphine analgesia

  2004cited by this paper
• Mu-opioid receptor binding measured by [11C]carfentanil positron emission tomography is related to craving and mood in alcohol dependence.

  2004cited by this paper
• Opioid receptors.

  2004cited by this paper
• Opioid Receptor Involvement in Food Deprivation-Induced Feeding: Evaluation of Selective Antagonist and Antisense Oligodeoxynucleotide Probe Effects in Mice and Rats

  2004cited by this paper
• Mu‐opioid receptor knockout mice show diminished food‐anticipatory activity

  2004cited by this paper
• Alterations in food intake by opioid and dopamine signaling pathways between the ventral tegmental area and the shell of the nucleus accumbens.

  2004cited by this paper
• Feared food in dieting and non-dieting young women: a preliminary validation of the Food Phobia Survey.

  2004cited by this paper
• Effects of sibutramine on binge eating, hunger, and fullness in a laboratory human feeding paradigm.

  2003cited by this paper
• The role of palatable food and hunger as trigger factors in an animal model of stress induced binge eating.

  2003influential reference
• Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial.

  2003cited by this paper
• Sugars and fats: the neurobiology of preference.

  2003cited by this paper
• Food sources of phyto-oestrogens and their precursors in Europe

  2003cited by this paper
• Nucleus Accumbens μ-Opioids Regulate Intake of a High-Fat Diet via Activation of a Distributed Brain Network

  2003cited by this paper
• Acute food deprivation and chronic food restriction differentially affect hypothalamic NPY mRNA expression.

  2003cited by this paper
• Restricted daily consumption of a highly palatable food (chocolate Ensure®) alters striatal enkephalin gene expression

  2003cited by this paper
• Effects of the opioid antagonist naltrexone on feeding induced by DAMGO in the ventral tegmental area and in the nucleus accumbens shell region in the rat.

  2003cited by this paper
• Nucleus accumbens opioid, GABaergic, and dopaminergic modulation of palatable food motivation: contrasting effects revealed by a progressive ratio study in the rat.

  2003cited by this paper
• Citalopram in the treatment of binge-eating disorder: a placebo-controlled trial.

  2003cited by this paper
• A double-blind, placebo-controlled trial of fluvoxamine in binge eating disorder: a high placebo response

  2003cited by this paper
• High fat feeding is associated with increased blood pressure, sympathetic nerve activity and hypothalamic mu opioid receptors.

  2003cited by this paper
• Basal and morphine‐evoked dopaminergic neurotransmission in the nucleus accumbens of MOR‐ and DOR‐knockout mice

  2003cited by this paper
• A randomized, double-blind, placebo-controlled study of sibutramine in the treatment of binge-eating disorder.

  2003cited by this paper
• Acquisition of a palatable-food-sustained appetitive behavior in satiated rats is dependent on the dopaminergic response to this food in limbic areas.

  2003cited by this paper
• Opioid receptor blockade in rat nucleus tractus solitarius alters amygdala dynorphin gene expression.

  2002cited by this paper
• Defense of body weight depends on dietary composition and palatability in rats with diet-induced obesity.

  2002cited by this paper
• Selective reward deficit in mice lacking beta-endorphin and enkephalin.

  2002cited by this paper
• Selective Reward Deficit in Mice Lacking β-Endorphin and Enkephalin

  2002cited by this paper
• A new animal model of binge eating: key synergistic role of past caloric restriction and stress.

  2002cited by this paper
• The Neuroscience of Natural Rewards: Relevance to Addictive Drugs

  2002cited by this paper
• Opioid peptides and the control of human ingestive behaviour.

  2002cited by this paper
• Diet-induced obesity increases mu opioid receptor binding in specific regions of the rat brain.

  2002cited by this paper
• Opioid modulation of taste hedonics within the ventral striatum.

  2002cited by this paper
• A placebo-controlled, randomized trial of fluoxetine in the treatment of binge-eating disorder.

  2002cited by this paper
• The Mu-Opioid Receptor Gene Polymorphism (A118G) Alters HPA Axis Activation Induced by Opioid Receptor Blockade

  2002cited by this paper
• Emotion and motivation: the role of the amygdala, ventral striatum, and prefrontal cortex.

  2002cited by this paper
• Diet-induced obesity increases μ opioid receptor binding in specific regions of the rat brain

  2002cited by this paper
• Effect of long-term naltrexone treatment on endocrine profile, clinical features, and insulin sensitivity in obese women with polycystic ovary syndrome.

  2002cited by this paper
• Excessive sugar intake alters binding to dopamine and mu-opioid receptors in the brain

  2001cited by this paper
• Naloxone's effect on meal microstructure of sucrose and cornstarch diets.

  2001cited by this paper
• Comparison of binge eating disorder and bulimia nervosa in a community sample.

  2001cited by this paper
• Heterodimerization of μ and δ Opioid Receptors: A Role in Opiate Synergy

  2000cited by this paper
• Enhanced intake of high-fat food following striatal mu-opioid stimulation: microinjection mapping and fos expression.

  2000cited by this paper

• Temporal hedonic regulation of feeding behavior in rainbow trout: a role for the opioid system under plant-based diets from first feeding onward

  2025cites this paper
• Efficacy of opioid antagonist in patients with binge eating behavior: A systemic review and meta-analysis.

  2025cites this paper
• Binge-type eating disorders and ultra-processed food addiction: phenomenology, pathophysiology and treatment implications

  2025cites this paper
• Deep transcriptome profiling of human hypothalamic agouti-related protein and proopiomelanocortin neurons regulating energy homeostasis

  2025cites this paper
• The involvement of the endogenous opioid system in binge eating, food devaluation and food reward in mice.

  2025cites this paper
• Role of Endogenous Opioids in the Pathophysiology of Obesity and Eating Disorders.

  2024cites this paper
• Endogenous Opioids in the Homeostatic Regulation of Hunger, Satiety, and Hedonic Eating: Neurobiological Foundations.

  2024cites this paper
• Effect of antorex, a new antagonist of orexin receptors, on binge eating in rats caused by weaning from the mother in early ontogenesis

  2024cites this paper
• Obesity-mediated lipoinflammation modulates food reward responses.

  2023cites this paper
• Снижение компульсивного переедания у крыс, вызванного материнской депривацией в раннем отногенезе, с применением нового антагониста рецепторов грелина агрелакс

  2023cites this paper
• Reduction of compulsive overeating in rats caused by maternal deprivation in early ontogenesis with the use of a new ghrelin receptor antagonist agrelax

  2023cites this paper
• Lateral hypothalamic proenkephalin neurons drive threat-induced overeating associated with a negative emotional state

  2023cites this paper
• The Role of Beta-Endorphin in Food Deprivation-Mediated Increases in Food Intake and Binge-Eating

  2023cites this paper
• Pharmacologic treatment of obesity

  2022cites this paper
• Prospects for new drugs to treat binge-eating disorder: Insights from psychopathology and neuropharmacology

  2021cites this paper
• Anorectic Effect, Biochemical and Hematological Profiles of Alkaloid Extract from Mitragyna speciosa Korth. in Rats

  2021cites this paper
• Anhedonia in Eating Disorders.

  2021cites this paper
• Converging Relationships of Obesity and Hyperuricemia with Special Reference to Metabolic Disorders and Plausible Therapeutic Implications Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy

  2020cites this paper
• Converging Relationships of Obesity and Hyperuricemia with Special Reference to Metabolic Disorders and Plausible Therapeutic Implications Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy

  2020cites this paper
• Current Long-Term Pharmacotherapies for the Management of Obesity

  2020cites this paper
• Converging Relationships of Obesity and Hyperuricemia with Special Reference to Metabolic Disorders and Plausible Therapeutic Implications

  2020cites this paper
• Lessons learned from using fMRI in the early clinical development of a mu-opioid receptor antagonist for disorders of compulsive consumption

  2020cites this paper
• Memory utility, food consumption and obesity

  2020cites this paper
• Binge Eating Disorder: A Psychiatrist's Commentary on Clinical Considerations.

  2020cites this paper
• Prevalence of obesity among U.S. population with substance dependence.

  2020cites this paper
• Binge eating disorder revisited: what’s new, what’s different, what’s next

  2019cites this paper
• Preclinical and Clinical Evidence for a Distinct Regulation of Mu Opioid and Type 1 Cannabinoid Receptor Genes Expression in Obesity

  2019cites this paper
• Animal Models of Type 2 Diabetes, Obesity and Nonalcoholic Steatohepatitis – Clinical Translatability and Applicability in Preclinical Drug Development

  2019cites this paper
• Systemic morphine administration causes gastric distention and hyperphagia in healthy horses.

  2019cites this paper
• Investigational drugs for the treatment of binge eating disorder (BED): an update

  2019cites this paper
• Sucrose intake lowers μ-opioid and dopamine D2/3 receptor availability in porcine brain

  2019cites this paper
• Psychopharmacological advances in eating disorders

  2018cites this paper
• Obesity and Stress: The Melanocortin Connection

  2018cites this paper
• Prevalence of obesity for opioid- and stimulant-dependent participants in substance use treatment clinical trials.

  2018cites this paper
• Belohnung und das Opioidsystem

  2018cites this paper
• Behaviour and Neural Indices of the Abuse Liability associated with Intraoral Self-administration of High Fructose Corn Syrup

  2018cites this paper
• Effects of taste stimulation on gastric myoelectrical activity and autonomic balance

  2018cites this paper
• Dopamine and μ-opioid receptor dysregulation in the brains of binge-eating female rats – possible relevance in the psychopathology and treatment of binge-eating disorder

  2017cites this paper
• Opioidergic and dopaminergic modulation of cost/benefit decision-making in Long Evans Rats.

  2017cites this paper
• Etude des liens entre fonctionnement exécutif, cognition sociale et facteurs psychopathologiques dans le contexte de l'obésité pédiatrique

  2017cites this paper
• Evaluation of the comprehensive palatability of Japanese sake paired with dishes by multiple regression analysis based on subdomains

  2017cites this paper
• Repository of the Radboud

  2017cites this paper
• Mu opioid receptor signaling in the nucleus accumbens shell increases responsiveness of satiety‐modulated lateral hypothalamus neurons

  2017cites this paper
• Casein kinase 1‐epsilon deletion increases mu opioid receptor‐dependent behaviors and binge eating 1

  2017cites this paper
• Changes in the incentive value of food after naltrexone treatment depend on a differential preference for a palatable food in male rats

  2017cites this paper
• Involvement of opioid signaling in food preference and motivation: Studies in laboratory animals.

  2016cites this paper
• [Genetics factors in pathogenesis and clinical genetics of binge eating disorder].

  2016cites this paper
• [Genetic aspects of binge eating disorder Part 2. Molecular genetics and pharmacogenetic approaches].

  2016cites this paper
• A primer on binge eating disorder diagnosis and management

  2015cites this paper
• Chasing the Dragon Away: Personality as a protective factor and extended-release naltrexone as a treatment for heroin dependence

  2015cites this paper
• Subchronic administration of short-acting naltrexone has no effect on striatal dopamine transporter availability, food intake or body weight gain in rats

  2015cites this paper
• The role of the opioid system in binge eating disorder

  2015influential citation
• The role of opioid processes in reward and decision‐making

  2015cites this paper
• Effects of lisdexamfetamine in a rat model of binge-eating

  2015cites this paper
• Genetic Similarities between Compulsive Overeating and Addiction Phenotypes: A Case for “Food Addiction”?

  2015cites this paper
• Knockdown of ventral tegmental area mu-opioid receptors in rats prevents effects of social defeat stress: implications for amphetamine cross-sensitization, social avoidance, weight regulation and expression of brain-derived neurotrophic factor.

  2015cites this paper
• Neurochemical Components of Undereating and Overeating

  2015cites this paper
• An Introduction to Neuroendocrinology: Neuropeptides II: function

  2015cites this paper
• Morphine effects on monetary reward: An fMRI pilot study

  2015cites this paper
• Intermittent-access binge consumption of sweet high-fat liquid does not require opioid or dopamine receptors in the nucleus accumbens.

  2015cites this paper
• Mu-Opioid Receptor - pAKT signaling in the Ventral Tegmental Area is Critical for the Behavioral and Cellular Consequences of Social Stress

  2015cites this paper
• Metabolic vs. hedonic obesity: a conceptual distinction and its clinical implications

  2015cites this paper
• Alleviating waiting impulsivity and perseverative responding by μ-opioid receptor antagonism in two inbred mouse strains

  2015cites this paper
• Title : The role of the opioid system in binge eating disorder

  2015cites this paper
• Changes in mu-opioid receptor expression and function in the mesolimbic system after long-term access to a palatable diet.

  2015cites this paper
• The effects of Beta-Endorphin: state change modification

  2015cites this paper
• On the behavioural specificity of hypophagia induced in male rats by mCPP, naltrexone, and their combination

  2014cites this paper
• Acute High Fat Diet Consumption Activates the Mesolimbic Circuit and Requires Orexin Signaling in a Mouse Model

  2014cites this paper
• Current Emotion Research in Health Behavior Science

  2014cites this paper
• Obesity at Conception Programs the Opioid System in the Offspring Brain

  2014cites this paper
• Opioid Hedonic Hotspot in Nucleus Accumbens Shell: Mu, Delta, and Kappa Maps for Enhancement of Sweetness “Liking” and “Wanting”

  2014cites this paper
• Effects of baclofen and naltrexone, alone and in combination, on the consumption of palatable food in male rats.

  2014cites this paper
• Opposing neural effects of naltrexone on food reward and aversion: implications for the treatment of obesity

  2014cites this paper
• Opioid system in the medial prefrontal cortex mediates binge‐like eating

  2014cites this paper
• Central nervous system biomarkers for antiobesity drug development☆

  2013cites this paper
• Upregulation of Gene Expression in Reward-Modulatory Striatal Opioid Systems by Sleep Loss

  2013cites this paper
• Dietary strategies to increase satiety.

  2013cites this paper
• Neural and Behavioral Effects of a Novel Mu Opioid Receptor Antagonist in Binge-Eating Obese People

  2013cites this paper
• A placebo-controlled pilot study of the novel opioid receptor antagonist ALKS-33 in binge eating disorder.

  2013cites this paper
• Attenuation of cocaine and heroin seeking by μ-opioid receptor antagonism

  2013cites this paper
• Principles of motivation revealed by the diverse functions of neuropharmacological and neuroanatomical substrates underlying feeding behavior.

  2013cites this paper
• The Opioid System and Food Intake: Homeostatic and Hedonic Mechanisms

  2012cites this paper
• Effects of the mu-opioid receptor antagonist GSK1521498 on hedonic and consummatory eating behaviour: a proof of mechanism study in binge-eating obese subjects

  2012cites this paper
• Is food addiction a valid and useful concept?

  2012cites this paper
• Dorsal Striatum and Its Limbic Connectivity Mediate Abnormal Anticipatory Reward Processing in Obesity

  2012cites this paper
• The endocannabinoid system modulates the valence of the emotion associated to food ingestion

  2012cites this paper
• GLP-1 neurons in the nucleus of the solitary tract project directly to the ventral tegmental area and nucleus accumbens to control for food intake.

  2012cites this paper
• From Disordered Eating to Addiction: The “Food Drug” in Bulimia Nervosa

  2012cites this paper
• Inhibition of Opioid Transmission at the μ-Opioid Receptor Prevents Both Food Seeking and Binge-Like Eating

  2012cites this paper
• Effects of mu opioid receptor antagonism on cognition in obese binge-eating individuals

  2012cites this paper
• Multiple‐Dose Safety, Pharmacokinetics, and Pharmacodynamics of the μ‐Opioid Receptor Inverse Agonist GSK1521498

  2012cites this paper
• Opioid Receptor Modulation of Hedonic Taste Preference and Food Intake: A Single‐Dose Safety, Pharmacokinetic, and Pharmacodynamic Investigation With GSK1521498, a Novel μ‐Opioid Receptor Inverse Agonist

  2012cites this paper
• The Role of the Opioid System in Reward Responsiveness

  2012cites this paper
• Episodic cognition : what is it, where is it, and when does it develop?

  2012cites this paper
• Taste and Food Choices

  2012cites this paper
• Hedonics of Food Consumption: Are Food ‘Liking’ and ‘Wanting’ Viable Targets for Appetite Control in the Obese?

  2012cites this paper
• Volume transmission of beta-endorphin via the cerebrospinal fluid; a review

  2012cites this paper
• Dysregulation of brain reward systems in eating disorders: neurochemical information from animal models of binge eating, bulimia nervosa, and anorexia nervosa.

  2012cites this paper
• Extending pharmacological spectrum of opioids beyond analgesia: multifunctional aspects in different pathophysiological states.

  2011cites this paper
• Pharmacological differentiation of opioid receptor antagonists by molecular and functional imaging of target occupancy and food reward-related brain activation in humans

  2011cites this paper